Post covid-19 syndrome. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Control group: Control group receives only supportive therapy including vitamin C, Famotidine, and Zinc (one tablet for each supplement) orally for 8 weeks. Intervention 2: Interventio
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: All Patients who have recovered from covid 19 but after three weeks the symptoms of post covid 19 syndrome remain
Exclusion criteria
Exclusion criteria: Pregnancy Immune deficiency patients Patients who use antipsychotic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Hair loss. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Skin rashes. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire.;Dyspnea. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score. Timepoint: Patients will be examined weekly during 9 weeks and the checklist will be completed for them. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShabnam tehrani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed